Rhythm Pharmaceuticals, Inc.
RYTM
$50.97
$0.731.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 320.57M | 298.39M | 319.13M | 201.20M | 275.85M |
| Total Receivables | 18.51M | 19.31M | 17.60M | 14.70M | 14.87M |
| Inventory | 18.74M | 13.90M | 11.99M | 8.51M | 8.62M |
| Prepaid Expenses | -- | 8.75M | 8.64M | 11.35M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.38M | -- | -- | -- | 8.93M |
| Total Current Assets | 374.20M | 340.34M | 357.37M | 235.75M | 308.27M |
|
|
|||||
| Total Current Assets | 374.20M | 340.34M | 357.37M | 235.75M | 308.27M |
| Net Property, Plant & Equipment | 4.11M | 4.39M | 4.67M | 1.82M | 2.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.17M | 6.39M | 6.60M | 6.82M | 7.03M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.79M | 12.45M | 13.21M | 14.26M | 15.33M |
| Total Assets | 392.27M | 363.57M | 381.85M | 258.65M | 332.75M |
|
|
|||||
| Total Accounts Payable | 12.33M | 4.89M | 4.54M | 7.55M | 4.89M |
| Total Accrued Expenses | 58.31M | 50.48M | 42.30M | 36.33M | 42.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.54M | -- | 816.00K | 793.00K | 770.00K |
| Total Finance Division Other Current Liabilities | 43.34M | 42.24M | 7.06M | 9.49M | 6.70M |
| Total Other Current Liabilities | 43.34M | 42.24M | 7.06M | 9.49M | 6.70M |
| Total Current Liabilities | 115.52M | 97.61M | 54.72M | 54.16M | 55.20M |
|
|
|||||
| Total Current Liabilities | 115.52M | 97.61M | 54.72M | 54.16M | 55.20M |
| Long-Term Debt | 108.27M | 109.24M | 108.37M | 107.37M | 106.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.94M | 4.03M | 3.30M | 284.00K | 490.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 35.96M | 35.26M | 1.15M |
| Total Liabilities | 227.72M | 210.88M | 202.35M | 197.07M | 162.99M |
|
|
|||||
| Common Stock & APIC | 1.18B | 1.12B | 1.11B | 1.10B | 1.06B |
| Retained Earnings | -1.16B | -1.11B | -1.07B | -1.04B | -894.74M |
| Treasury Stock & Other | -39.00K | -604.00K | -617.00K | -181.00K | 134.00K |
| Total Common Equity | 21.73M | 11.22M | 39.34M | 61.58M | 169.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 142.82M | 141.48M | 140.15M | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 142.82M | 141.48M | 140.15M | -- | -- |
|
|
|||||
| Total Common Equity | 21.73M | 11.22M | 39.34M | 61.58M | 169.76M |
| Total Preferred Equity | 142.82M | 141.48M | 140.15M | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 164.55M | 152.70M | 179.50M | 61.58M | 169.76M |
|
|
|||||
